The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMPM.L Regulatory News (MPM)

  • There is currently no data for MPM

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Board Changes

23 Feb 2018 07:00

RNS Number : 7155F
mporium Group PLC
23 February 2018
 

23 February 2018

Mporium Group plc 

 

("Mporium" or the "Company") 

 

Board Changes

 

Mporium Group plc (AIM:MPM), the technology firm delivering event-driven marketing, is pleased to announce the appointment of Nicholas Bertolotti as Non-Executive Director of the Company.

 

Nick has spent over 25 years advising companies in the Technology, Media and Telecoms ("TMT") sector. From 2003 to 2016 he was a Managing Director in Investment Banking at Credit Suisse, where he headed up the European Media Equity Research team, and where he was voted many times the number one rated European media analyst in the Extel and Institutional Investor surveys. He joined Credit Suisse from JPMorgan, where he spent seven years, latterly as a Managing Director and head of the European Media Equity Research team.

 

Prior to this Nick worked at Arthur Andersen (now Deloitte) as a Partner in Financial Consulting Services advising primarily TMT companies on strategy, operations, marketing, international expansion, M&A, investment and valuation. He holds a BSc degree in Economics and Accounting from the University of Bristol (1983), qualified as an ACA Chartered Accountant in 1987 and has an MBA from Cambridge University Judge Business School (1992).

 

The Group also announces that Staale Bjornstad, Non-Executive Director, will be stepping down from the Board with immediate effect. Since joining the Board in June 2015, Staale has provided valuable insight to the business and strong support in the development of its proprietary technology. The Board thanks Staale for his significant contribution and wishes him the best in his future endeavours.

 

Barry Moat, Chairman of Mporium, said:

 

"I am delighted that Nick has agreed to join the Board. With his unrivalled sector experience, his appointment speaks volumes of the quality of our technology and market opportunity. As well as being able to draw on Nick's vast experience in his counsel to the Board, he will also provide unrivalled access to the contacts that he has built over the last 25 years in the Media and Tech industries and in the general financial markets."

 

Other Information 

 

In relation to the appointment of Mr Bertolotti, the Company confirms that there is no further information to be disclosed under paragraph (g) of Schedule 2 of the AIM Rules for Companies save as disclosed below:

 

Full Name:

Nicholas Bertolotti

Age:

55

Current Directorships /Partnerships

Previous Directorships

None

Telemetry Limited

Enquiries

 

Mporium:

020 3841 8411

Nelius De Groot, Chief Executive Officer

N+1 Singer:

020 7496 3000

Mark Taylor

Michael Taylor

Alex Laughton-Scott

Alma PR:

020 3865 9668

Rebecca Sanders-Hewett

Josh Royston

Susie Hudson

Sam Modlin

 

Notes to editors

 

About Mporium

 

Mporium is a technology company at the forefront of the transformation in digital marketing. Mporium's proprietary technology enables advertisers, to identify and monetise micro-moments - those moments when there are significant changes in the levels of consumer intent. Using technologies derived from financial services, these micro-moments are used to drive highly performant digital advertising campaigns: from brand advertising to direct response.

 

Based in the UK, Mporium Group plc is quoted on AIM, the junior market of the London Stock Exchange plc.

 

www.mporium.com

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOATTMPTMBBTBRP
Date   Source Headline
27th Jun 20087:00 amRNSAHS Meeting
25th Jun 200810:28 amRNSDirector/PDMR Shareholding
24th Jun 200810:23 amRNSResult of Annual General Meet
24th Jun 20087:00 amRNSAGM Statement
16th Jun 20087:30 amRNSTEMPUS study fully enrolled
4th Jun 20087:00 amRNSAnnual Report and Accounts
2nd Jun 20087:00 amRNSUS Marketing Consultant
22nd May 20087:00 amRNSPreliminary Results
12th Mar 20087:00 amRNSAura trial fully enrolled
5th Feb 20087:00 amRNSTEMPUS Trial Update
3rd Dec 20077:00 amRNSInterim Results
16th Oct 20077:00 amRNSTEMPUS trial starts in US
4th Oct 200711:06 amRNSChange of Registered Office
28th Sep 200711:32 amRNSDirector/PDMR Shareholding
17th Aug 20077:00 amRNSAIM Rule 26
16th Jul 200711:29 amRNSResult of AGM
16th Jul 20077:00 amRNSAGM Statement
2nd Jul 20074:13 pmRNSHolding(s) in Company
27th Jun 20077:01 amRNSIHS Scientific Meeting
21st Jun 20075:05 pmRNSAnnual Report and Accounts
13th Jun 20077:02 amRNSPreliminary Results
7th Jun 20077:02 amRNSAHS Scientific Meeting
1st Jun 20078:30 amRNSTotal Voting Rights
18th May 20079:20 amRNSAdditional Listing
30th Apr 20076:22 pmRNSHolding(s) in Company
30th Apr 200712:16 pmRNSTotal Voting Rights
11th Apr 20074:39 pmRNSConversion of Loan Note
2nd Apr 20073:27 pmRNSHolding(s) in Company
2nd Apr 20072:55 pmRNSHolding(s) in Company
2nd Apr 20071:26 pmRNSDirector/PDMR Shareholding
30th Mar 20079:32 amRNSTotal Voting Rights
27th Mar 20077:01 amRNSBoard Appointments
26th Mar 200710:31 amRNSResult of EGM
2nd Mar 20077:30 amRNSGPB17m fundraising
9th Jan 20077:01 amRNSPositive Tonabersat Study
20th Dec 20065:43 pmRNSTotal Voting Rights
1st Dec 20067:01 amRNSInterim Results
17th Nov 20067:01 amRNSPlacing
25th Oct 200610:20 amRNSResult of AGM
25th Oct 20067:01 amRNSAGM Statement
27th Sep 20067:00 amRNSNIH Collaboration
20th Sep 20067:02 amRNSPreliminary Results
7th Sep 20067:00 amRNSAdditional Indications
15th Aug 200611:37 amRNSNotification of Interests
20th Jun 20067:00 amRNSStart of Phase II Trial
24th May 20067:01 amRNSUCLA Collaboration
21st Mar 20067:00 amRNSStart of Phase II Trial
8th Mar 20067:03 amRNSChange of Adviser
13th Jan 20067:00 amPRNRe Agreement
8th Dec 20057:00 amPRNInterim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.